HMGN (HMGN) Stock Price & Analysis
HMGN (HMGN) rose 0.00% to USD 0 as of September 8, 2026 at 14:08 UTC, according to Nexqual real-time market data.
HMGN last closed at USD 0; the session ranged USD 0.02–0.02 on volume of 50,000 shares. Market capitalization is —, with a 52-week range of USD 0–0.13 (PNK). Source: Nexqual, September 8, 2026 at 14:08 UTC.
Key Statistics (as of September 8, 2026 at 14:08 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 50,000 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (HMGN)
Nexqual's technical model rates HMGN "STRONG SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 14:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| ICCC | ImmuCell Corporation | USD 9.9 | ▼ 1.05% |
| HXBM | Helix BioMedix, Inc. | USD 6.5 | ▲ 0% |
| HDII | Hypertension Diagnostics, Inc. | USD 0 | ▲ 0% |
| MYMX | MYMETICS CORPORATION | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:08 UTC. This page is informational and not investment advice.